Znomics, Inc. Appoints Pharmaceutical Drug Discovery Expert, Bruce A. Beutel, Ph.D., as New Chief Scientific Officer

PORTLAND, Ore., June 11, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today announced that it has named Bruce A. Beutel, Ph.D. as the company's new chief scientific officer, succeeding Roger Cone, Ph.D. Dr. Cone has accepted the position of chairman of the Department of Molecular Physiology and Biophysics at Vanderbilt University Medical Center, starting in August, but will continue as a scientific consultant to Znomics and as an active member of the company's board of directors. Dr. Beutel's appointment is effective June 16, 2008.